Treatment of myocardial infarction should be audited before heart failure clinics are set up.
A D
AD
Timmis
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D016507:Cardiology Service, Hospital / Q000458:organization & administration*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D008485:Medical Audit; D009203:Myocardial Infarction / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors